Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate the Use of Resources and the Costs Associated With Controlled or Uncontrolled Carcinoid Syndrome in Patients With Neuroendocrine Tumours (NETs) in Spain

NCT03220087 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT03220087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03220087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate the Use of Resources and the Costs Associated With Controlled or Uncontrolled Carcinoid Syndrome in Patients With Neuroendocrine Tumours (NETs) in Spain
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
July 21, 2017
Completion date
April 30, 2018
Enrollment
142 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

neuroendocrine tumors